Experiences of HSCT treatment for Multiple Sclerosis
Research type
Research Study
Full title
Expectations and Experiences of Haematopoietic Stem Cell Transplant Treatmentation for Multiple Sclerosis
IRAS ID
248788
Contact name
Maria Burton
Contact email
Sponsor organisation
Sheffield Hallam University
Clinicaltrials.gov Identifier
STH20680, Sheffield Teaching Hospitals NHS Foundation Trust
Duration of Study in the UK
4 years, 8 months, 19 days
Research summary
The aim of the study is to explore the expectations and experiences of people receiving Hematopoietic stem cell Transplantation (HSCT) as a treatment for relapse remitting multiple sclerosis (MS).
Methodology
A longitudinal, qualitative research study over a twelve month period will be conducted, based on phenomenology and interpretative phenomenological analysis (IPA).
Data Collection
Purposive sampling will recruit a maximum of 12 patients (minimum 8)aged 18+ receiving their HSCT treatment within one NHS site in the North of England. Data collection methods will include semi-structured interviews and a reflective art-based activity based on the KAWA model, as a tool to facilitate discussion. Interviews will commence 2 weeks before HSCT treatment, and then at 6 weeks, 4 months and 12 months post treatment.
Data Analysis
The principles of IPA will be applied for data analysis, in order to sort raw data into conceptual categories and seek to find themes which arise.REC name
Yorkshire & The Humber - South Yorkshire Research Ethics Committee
REC reference
19/YH/0108
Date of REC Opinion
2 Apr 2019
REC opinion
Favourable Opinion